- Titre
- CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized monoclonal anti-CD4 treatment of active rheumatoid arthritis
- Créateurs - sans rôle
- Ursula Mason - Department of Rheumatology, GlaxoSmithKline Pharmaceuticals, Greenford, United KingdomJose Aldrich - Department of Rheumatology, Medical Plaza at Coral Gables, Miami, Florida, United StatesMark Totoritis - Department of Rheumatology, IDEC Pharmaceuticals, San Diego, CA, United StatesAlemseged Truneh - Department of Rheumatology, GlaxoSmithKline Pharmaceuticals, Greenford, United KingdomMichael Weisman - Department of Rheumatology, University of California, San Diego, California, United StatesCraig Wiesenhutter - Department of Rheumatology, Coeur d'Alene Arthritis Center, Coeur d'Alene, Idaho, United StatesDavid Yocum - Department of Rheumatology, Arizona Health Sciences Center, Tucson, Arizona, United StatesJIN Zhu - Department of Rheumatology, GlaxoSmithKline Pharmaceuticals, Philadelphia, Pennsylvania, United StatesFerdinand Breedveld - Leiden UniversityCharles B Davis - Department of Rheumatology, GlaxoSmithKline Pharmaceuticals, Philadelphia, Pennsylvania, United StatesMichael Elliott - Department of Rheumatology, GlaxoSmithKline Pharmaceuticals, Greenford, United KingdomMildred Jackson - Department of Rheumatology, GlaxoSmithKline Pharmaceuticals, Philadelphia, Pennsylvania, United StatesChristian Jorgensen - Hôpital LapeyronieEdward Keystone - University of TorontoRobert Levy - Department of Rheumatology, Olympia Arthritis Center, Olympia, Washington, United StatesJohn Tesser - Department of Rheumatology, Phoenix Center for Clinical Research, Phoenix, Arizona, United States
- Détails de publication
- Journal of rheumatology, Vol.29(2), pp.220-229
- Éditeur
- Journal of Rheumatology Publishing
- Nombre de pages
- 10
- Identifiants
- 99141101809311
- Unité académique
- Cell souches plasticité cellul régénérat tissulaire immuno des maladies inflamm - IRMB
- Langue
- English
- Type de ressource
- Journal article
Article de revue
CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized monoclonal anti-CD4 treatment of active rheumatoid arthritis
Journal of rheumatology, Vol.29(2), pp.220-229
01/02/2002
PMID: 11838838
Indicateurs
1 Consultations de la notice